Cell Care Therapeutics, Inc., a biotechnology company whose mission is to advance stem-cell derived therapies in ophthalmology, today announced the closing of a $4.3 million seed round investment...
Read More »Cell Care Therapeutics, Inc., a biotechnology company whose mission is to advance stem-cell derived therapies in ophthalmology, today announced the closing of a $4.3 million seed round investment...
Read More »